Undurti N. Das

Metabolic Syndrome Pathophysiology

The Role of Essential Fatty Acids

• Gebundenes Buch

Produktbeschreibung

Metabolic Syndrome Pathophysiology: The Role of Essential Fatty Acids
Metabolic Syndrome Pathophysiology: The Role of Essential Fatty Acids provides current research exploring the links among insulin, insulin receptors, polyunsaturated fatty acids, brain growth and disease. Specific interactions of essential fatty acids and polyunsaturated fatty acids in brain development and several disease groups are described. The role of inflammation in disease and how fatty acids regulate low-systemic inflammation are examined and explained. Metabolic and neurologic dynamics are presented to provide a linkage between the presence of omega-3 and omega-6 and protection against diseases and conditions such as diabetes mellitus, obesity, autoimmune diseases and hypertension.
Preliminary chapters provide an overview of the history and diagnosis of metabolic syndrome and its link to insulin resistance. Following chapters cover obesity, hypertension and diabetes, and remaining chapters provide detailed information on the role and physiology of essential fatty acids.
This book is a key reference for nutrition researchers and clinical nutritionists working in the areas of lipids and metabolism, metabolic syndrome, obesity, hypertension and diabetes.
Comprehensively reviews current research on metabolic diseases
Discusses molecular aspects of biochemistry, physiology, and pathology of metabolism of essential fatty acids
Includes chapters devoted to obesity, hypertension, heart disease and certain cancers Metabolic Syndrome Pathophysiology: The Role of Essential Fatty Acids provides current research exploring the links among insulin, insulin receptors, polyunsaturated fatty acids, brain growth and disease. Specific interactions of essential fatty acids and polyunsaturated fatty acids in brain development and several disease groups are described. The role of inflammation in disease and how fatty acids regulate low-systemic inflammation are examined and explained. Metabolic and neurologic dynamics are presented to provide a linkage between the presence of omega-3 and omega-6 and protection against diseases and conditions such as diabetes mellitus, obesity, autoimmune diseases and hypertension.

Produktdetails

• Verlag: Wiley & Sons
• 1. Auflage
• Seitenzahl: 268
• Erscheinungstermin: 23. Februar 2010
• Englisch
• Abmessung: 246mm x 175mm x 18mm
• Gewicht: 717g
• ISBN-13: 9780813815534
• ISBN-10: 0813815533
• Artikelnr.: 28708013

Autorenporträt

Undurti N. Das, M.D. is the Chairman and Research Director of UND Life Sciences, USA and Ramalingaswami Fellow of the Department of Biotechnology, India. Dr Das is also the Editor-in-Chief of the journal Lipids in Health and Disease. He has published more than 400 international publications and has been awarded four USA patents.

Inhaltsangabe

Chapter 1: Introduction. Chapter 2: History, definition and diagnosis of
the metabolic Syndrome. Chapter 3: Insulin resistance in the metabolic
syndrome. Chapter 4: Is it necessary to redefine the metabolic syndrome?
Chapter 5: Is insulin resistance a disorder of the brain? Chapter 6:
Obesity. Chapter 7: Perinatal nutrition and obesity. Chapter 8: Essential
hypertension. Chapter 9: Dietary factors and hypertension. Chapter 10: Is
hypertension a disorder of the brain? Chapter 11: Type 2 diabetes mellitus.
Chapter 12: Pathophysiology of type 2 diabetes mellitus with particular
reference to hypothalamus. Chapter 13: Insulin and insulin receptors in the
brain and their role in the pathogenesis of obesity and type 2 diabetes
mellitus. Chapter 14: Insulin, endothelial nitric oxide and the metabolic
syndrome. Chapter 15: Obesity, type 2 diabetes mellitus and the metabolic
syndrome and the gut microbiota. Chapter 16: Is it possible that the
metabolic syndrome originates in the perinatal period? Chapter 17:
Essential fatty acids: biochemistry and Physiology. Chapter 18: Role of
EFAs/PUFAs in brain growth and development and pathophysiology of the
metabolic syndrome. Chapter 19: EFAs/PUFAs and their metabolites in insulin
resistance. Chapter 20: EFAs/PUFAs and atherosclerosis.